RVNC logo

Revance Therapeutics (RVNC) Company Overview

Profile

Full Name:

Revance Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 6, 2014

Indexes:

Not included

Description:

Revance Therapeutics (RVNC) is a biotechnology company focused on developing innovative treatments for various medical conditions. They specialize in neuromodulators and other therapies, aiming to improve patient outcomes in areas like aesthetics and therapeutic applications. Their products include DaxibotulinumtoxinA for cosmetic and therapeutic uses.

Key Details

Price

$3.65

Annual Revenue

$234.04 M(+76.55% YoY)

Annual EPS

-$3.83(+21.84% YoY)

Annual ROE

213.71%

Beta

1.40

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 17, 25 Needham
Hold
Dec 23, 24 Barclays
Equal-Weight
Dec 10, 24 Mizuho
Neutral
Nov 8, 24 Needham
Hold
Nov 8, 24 HC Wainwright & Co.
Neutral
Oct 28, 24 Needham
Hold
Sep 13, 24 Barclays
Equal-Weight
Aug 13, 24 Needham
Hold
Aug 12, 24 William Blair
Market Perform
Aug 12, 24 Guggenheim
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Revance Therapeutics?
  • Does Revance Therapeutics pay dividends?
  • What sector is Revance Therapeutics in?
  • What industry is Revance Therapeutics in?
  • What country is Revance Therapeutics based in?
  • When did Revance Therapeutics go public?
  • Is Revance Therapeutics in the S&P 500?
  • Is Revance Therapeutics in the NASDAQ 100?
  • Is Revance Therapeutics in the Dow Jones?
  • When was Revance Therapeutics's last earnings report?
  • When does Revance Therapeutics report earnings?
  • Should I buy Revance Therapeutics stock now?

What is the ticker symbol for Revance Therapeutics?

The ticker symbol for Revance Therapeutics is NASDAQ:RVNC

Does Revance Therapeutics pay dividends?

No, Revance Therapeutics does not pay dividends

What sector is Revance Therapeutics in?

Revance Therapeutics is in the Healthcare sector

What industry is Revance Therapeutics in?

Revance Therapeutics is in the Biotechnology industry

What country is Revance Therapeutics based in?

Revance Therapeutics is headquartered in United States

When did Revance Therapeutics go public?

Revance Therapeutics's initial public offering (IPO) was on February 6, 2014

Is Revance Therapeutics in the S&P 500?

No, Revance Therapeutics is not included in the S&P 500 index

Is Revance Therapeutics in the NASDAQ 100?

No, Revance Therapeutics is not included in the NASDAQ 100 index

Is Revance Therapeutics in the Dow Jones?

No, Revance Therapeutics is not included in the Dow Jones index

When was Revance Therapeutics's last earnings report?

Revance Therapeutics's most recent earnings report was on Nov 7, 2024

When does Revance Therapeutics report earnings?

The next expected earnings date for Revance Therapeutics is Feb 28, 2025

Should I buy Revance Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions